Literature DB >> 30159362

An overview of process intensification and thermo stabilization for upscaling of Peste des petits ruminants vaccines in view of global control and eradication.

Mousumi Bora1, Raja Wasim Yousuf1, Pronab Dhar2, Rabindra Prasad Singh1.   

Abstract

Peste des petits ruminants (PPR) has been recognized as a globally distributed disease affecting the small ruminant population. The disease results in severe economic losses mainly to small land holders and low input farming systems. The control of PPR is mainly achieved through vaccination with available live attenuated vaccines. The thermo labile nature of PPR virus poses a major constraint in production of quality vaccines which often results in vaccine failures. The lack of quality vaccine production jeopardize the wide vaccination coverage especially in countries with poor infrastructure due to which PPR persists endemically. The vaccine production system may require augmentation to attain consistent and quality vaccines through efforts of process intensification integrated with suitable stabilizer formulations with appropriate freeze drying cycles for improved thermo tolerance. Manufacturing of live attenuated PPR vaccines during batch cultures might introduce defective interfering particles (DIPs) as a result of high multiplicity of infection (MOI) of inoculums, which has a huge impact on virus dynamics and yield. Accumulation of DIPs adversely affects the quality of the manufactured vaccines which can be avoided through use of appropriate MOI of virus inoculums and quality control of working seed viruses. Therefore, adherence to critical manufacturing standard operating procedures in vaccine production and ongoing efforts on development of thermo tolerant vaccine will help a long way in PPR control and eradication programme globally. The present review focuses on the way forward to achieve the objectives of quality vaccine production and easy upscaling to help the global PPR control and eradication by mass vaccination as an important tool.

Entities:  

Keywords:  Defective interfering (DI) particles; PPR; Process intensification; Thermo stability; Upscaling

Year:  2018        PMID: 30159362      PMCID: PMC6111956          DOI: 10.1007/s13337-018-0455-3

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  67 in total

1.  Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virus.

Authors:  M U Lancaster; S I Hodgetts; J S Mackenzie; N Urosevic
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.

Authors:  G W Wertz; V P Perepelitsa; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay.

Authors:  Lisa D Schlehuber; Iain J McFadyen; Yu Shu; James Carignan; W Paul Duprex; William R Forsyth; Jason H Ho; Christine M Kitsos; George Y Lee; Douglas A Levinson; Sarah C Lucier; Christopher B Moore; Niem T Nguyen; Josephine Ramos; B André Weinstock; Junhong Zhang; Julie A Monagle; Colin R Gardner; Juan C Alvarez
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

4.  Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine.

Authors:  P Calain; L Roux
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  Response of white-tailed deer to infection with peste des petits ruminants virus.

Authors:  F M Hamdy; A H Dardiri
Journal:  J Wildl Dis       Date:  1976-10       Impact factor: 1.535

6.  Defective interfering particle generated by internal deletion of the vesicular stomatitis virus genome.

Authors:  D A Epstein; R C Herman; I Chien; R A Lazzarini
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

Review 7.  Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control.

Authors:  Ashley C Banyard; Satya Parida; Carrie Batten; Chris Oura; Olivier Kwiatek; Genevieve Libeau
Journal:  J Gen Virol       Date:  2010-09-15       Impact factor: 3.891

8.  Generation of defective interfering particles by two vaccine strains of measles virus.

Authors:  T Whistler; W J Bellini; P A Rota
Journal:  Virology       Date:  1996-06-15       Impact factor: 3.616

9.  Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex.

Authors:  M Mahapatra; S Parida; M D Baron; T Barrett
Journal:  J Gen Virol       Date:  2006-07       Impact factor: 3.891

10.  Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.

Authors:  Timo Frensing; Frank Stefan Heldt; Antje Pflugmacher; Ilona Behrendt; Ingo Jordan; Dietrich Flockerzi; Yvonne Genzel; Udo Reichl
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more
  4 in total

Review 1.  Progress towards Eradication of Peste des Petits Ruminants through Vaccination.

Authors:  Hang Zhao; Felix Njeumi; Satya Parida; Camilla T O Benfield
Journal:  Viruses       Date:  2021-01-05       Impact factor: 5.048

Review 2.  A Review of the Current Status of Peste des Petits Ruminants Epidemiology in Small Ruminants in Tanzania.

Authors:  Enokela S Idoga; Bryony Armson; Ruth Alafiatayo; Adah Ogwuche; Erik Mijten; Abel B Ekiri; Gabriel Varga; Alasdair J C Cook
Journal:  Front Vet Sci       Date:  2020-11-25

3.  Pheno- and genotypic characterization and identification of novel subtypes of Peste des Petits Ruminants virus in domestic and captive wild goats in Northern Iraq.

Authors:  Faisal Polis Khoran; Elham Potros Candlan; Abdulwahed Ahmed Hassan; Fanar A Isihak; Amir Abdulmawjood; Izhar U H Khan
Journal:  BMC Microbiol       Date:  2021-12-07       Impact factor: 3.605

4.  Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.

Authors:  Qu-Lai Tang; Li-Xing Gu; Yao Xu; Xing-Hua Liao; Yong Zhou; Tong-Cun Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.